Skip to main content
logo
City Therapeutics, Inc. (CTY)
NASDAQ: CTY · Real-Time Price · USD
22.40
+4.40 (24.44%)
At close: Oct 16, 2026, 4:00 PM EDT
22.15
-0.25 (-1.12%)
After-hours: Oct 16, 2026, 7:58 PM EDT

City Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
169.61112.79126.9
Cash & Short-Term Investments
169.61112.79126.9
Cash Growth
--11.12%-
Receivables
5.121.211.35
Prepaid Expenses
0.962.870.65
Total Current Assets
175.69116.87128.9
Property, Plant & Equipment
29.4930.3514.88
Other Long-Term Assets
2.542.551.57
Total Assets
208.61149.77145.35

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
5.112.72.34
Accrued Expenses
8.87.281.48
Current Portion of Long-Term Debt
33.0910.8110.28
Current Portion of Leases
5.135.083.09
Current Unearned Revenue
10.7911.263.36
Other Current Liabilities
1.850.930.2
Total Current Liabilities
64.7638.0420.74
Long-Term Debt
-31.06-
Long-Term Leases
18.8220.348.93
Long-Term Unearned Revenue
--0.6
Other Long-Term Liabilities
0.690.46-
Total Liabilities
84.2789.9130.26

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Additional Paid-In Capital
10.834.451.17
Retained Earnings
-142.55-89.1-30.6
Total Common Equity
-131.72-84.66-29.43
Shareholders' Equity
124.3459.86115.09
Total Liabilities & Equity
208.61149.77145.35

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
57.0467.2822.3
Net Cash (Debt)
112.5745.51104.6
Net Cash Growth
--56.49%-
Net Cash Per Share
20.199.6930.73
Filing Date Shares Outstanding
5.295.183.4
Total Common Shares Outstanding
5.295.183.4
Working Capital
110.9378.83108.16
Book Value Per Share
-24.91-16.34-8.64
Tangible Book Value
-131.72-84.66-29.43
Tangible Book Value Per Share
-24.91-16.34-8.64
Machinery
7.56.023.72
Leasehold Improvements
1.071.071.07
SEC Filings: 10-K · 10-Q